Johnson & Johnson (NYSE:JNJ) declared a quarterly dividend on Thursday, October 19th, RTT News reports. Stockholders of record on Tuesday, November 28th will be given a dividend of 0.84 per share on Tuesday, December 12th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date of this dividend is Monday, November 27th.

Johnson & Johnson has increased its dividend payment by an average of 6.7% per year over the last three years and has raised its dividend annually for the last 54 consecutive years. Johnson & Johnson has a dividend payout ratio of 46.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect Johnson & Johnson to earn $7.75 per share next year, which means the company should continue to be able to cover its $3.36 annual dividend with an expected future payout ratio of 43.4%.

Johnson & Johnson (NYSE:JNJ) opened at 140.68 on Thursday. Johnson & Johnson has a 52-week low of $109.32 and a 52-week high of $141.58. The firm has a market cap of $377.58 billion, a price-to-earnings ratio of 23.80 and a beta of 0.78. The stock has a 50 day moving average of $133.17 and a 200-day moving average of $130.54.

Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.68%. The company had revenue of $19.65 billion during the quarter, compared to analysts’ expectations of $19.29 billion. During the same period last year, the company posted $1.68 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, analysts expect that Johnson & Johnson will post $7.19 EPS for the current year.

JNJ has been the subject of a number of research analyst reports. Royal Bank Of Canada reissued a “buy” rating and issued a $138.00 price target on shares of Johnson & Johnson in a research report on Wednesday, July 12th. BidaskClub lowered shares of Johnson & Johnson from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 1st. UBS AG reissued a “buy” rating and issued a $148.00 price target (up from $136.00) on shares of Johnson & Johnson in a research report on Wednesday, July 19th. Zacks Investment Research raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $148.00 price target for the company in a research report on Thursday, July 27th. Finally, Credit Suisse Group reissued a “buy” rating on shares of Johnson & Johnson in a research report on Friday, August 4th. Five investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $141.39.

In other news, VP Paulus Stoffels sold 102,692 shares of the business’s stock in a transaction on Monday, July 24th. The shares were sold at an average price of $133.14, for a total value of $13,672,412.88. Following the sale, the vice president now owns 230,342 shares in the company, valued at approximately $30,667,733.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is owned by insiders.

Several large investors have recently modified their holdings of the company. Landmark Financial Advisors LLC boosted its stake in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Landmark Financial Advisors LLC now owns 1,962 shares of the company’s stock valued at $259,000 after purchasing an additional 7 shares in the last quarter. Premier Asset Management LLC boosted its stake in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Premier Asset Management LLC now owns 2,749 shares of the company’s stock valued at $363,000 after purchasing an additional 12 shares in the last quarter. Lbmc Investment Advisors LLC boosted its stake in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Lbmc Investment Advisors LLC now owns 3,718 shares of the company’s stock valued at $492,000 after purchasing an additional 14 shares in the last quarter. Halbert Hargrove Russell LLC boosted its stake in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Halbert Hargrove Russell LLC now owns 3,523 shares of the company’s stock valued at $466,000 after purchasing an additional 15 shares in the last quarter. Finally, Lenox Wealth Management Inc. boosted its stake in shares of Johnson & Johnson by 1.7% in the 2nd quarter. Lenox Wealth Management Inc. now owns 1,457 shares of the company’s stock valued at $193,000 after purchasing an additional 24 shares in the last quarter. Institutional investors own 65.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.americanbankingnews.com/2017/10/19/johnson-johnson-jnj-plans-quarterly-dividend-of-0-84.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Dividend History for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.